Mission and advantages
  Extensive experience
  Benefits and clients
  Consulting and services
  Mecical services
  Season's Greetings 2015
  BPI Position Paper 2015
  Season's Greetings 2014
  Season's Greetings 2013
  Season's Greetings 2012
  Season's Greetings 2011
  Season's Greetings 2010
  Season's Greetings 2009
  Season's Greetings 2008
  Season's Greetings 2007
  Phone / E-Mail / Fax
  Partner & Societies

Scientific and strategic consulting
DR. RIETHMÜLLER M/R/S is able to provide all of the services listed below. Please feel free to contact us should you require any additional information.

Preclinic and clinic
The company prepares and evaluates detailed development plans, including pharmaceutical development, pharmacology, toxicology, pharmacokinetics and clinical Phases I to IV. We respect ICH-GMP, GLP, GCP and regional guidelines (FDA, CHMP).

Cost calculations of developments are performed.

Services and scientific areas
We set up files for

Marketing authorization approval
Orphan drug designation
Product pricing.

In Europe we prepare submissions/notifications to conduct clinical studies
Investigational Medicinal Product Dossier (IMPD)
EudraCT Number
Ethic Committee.

For the successful performance of clinical studies we cooperate with highly qualified
Clinical investigators and experts
CROs: monitoring of studies, statistics
Health authorities.

Clinical and preclinical activities have been carried out by us in numerous benign and oncologic indications, e.g. CNS, cardiovascular, respiratory, metabolic, endocrine, infectious, immunologic, gastro-intestinal, gynecologic and urologic diseases, and in the treatment of pain.

Longstanding experience has been gained by the team with new small chemical entities, recombinant drugs, antibodies, generics, and phytopharmaceuticals.